Negative symptom dimensions link cognitive impairment to global and social functioning in 22q11.2 deletion syndrome
Schizophrenia Research · 2026
DOI: 10.1016/j.schres.2026.07.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2026. Verfasst von David A Parker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Atlanta Veterans Administration Health Care System, Mental Health 116/A, 1670 Clairmont Road, Decatur, GA, USA; Department of Psychiatry and Behavior…. Hauptthemen laut MEDLINE: DiGeorge Syndrome, Cognitive Dysfunction, Attention Deficit Disorder with Hyperactivity, Autism Spectrum Disorder. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
BACKGROUND: 22q11.2 deletion syndrome (22q11DS) confers a 20-30% lifetime risk of schizophrenia, with negative symptoms associated with poorer outcomes and higher psychosis risk. High rates of neurocognitive deficits, autism spectrum traits (ASD), and attention-deficit/hyperactivity disorder (ADHD) may further complicate symptom profiles and functional outcomes. We examined relationships among positive and negative symptom severity, ASD traits, ADHD symptoms, and global functioning in 22q11DS. METHODS: Individuals with 22q11DS (n = 38) and healthy comparison subjects (n = 34) completed clinical and cognitive assessments. Exploratory factor analysis (EFA) of the 19 items on the Structured Interview for Psychosis-Risk Syndromes (SIPS) derived empirical symptom dimensions. Group differences were evaluated using Mann-Whitney U tests. Mediation analyses examined whether SIPS-derived factors mediated relationships between cognition and three domains: global functioning, ASD traits, and ADHD symptom severity. RESULTS: EFA identified three symptom dimensions: (1) Positive/Disorganized, (2) Negative-Motivational, and (3) Negative-Expressive. Compared to healthy comparisons, 22q11DS subjects showed elevated scores across all three symptom dimensions, ASD subscales, and ADHD domains (except hyperactivity/restlessness), alongside significant neurocognitive and global functioning impairments. The Negative-Expressive factor was the strongest mediator, showing the largest indirect effects for global functioning and ASD traits. The Negative-Motivational factor was the only dimension to significantly mediate all three outcomes. The Positive/Disorganized factor mediated effects only on global functioning and ASD traits. CONCLUSION: Negative-expressive symptoms represent a core pathway linking cognitive deficits to functional impairment in 22q11DS, while motivational and positive symptom dimensions contribute differentially across functional domains. Expressive and motivational symptoms may represent candidate targets for future longitudinal and intervention studies in 22q11DS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Atlanta Veterans Administration Health Care System, Mental Health 116/A, 1670 Clairmont Road, Decatur, GA, USA; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr…
- Atlanta Veterans Administration Health Care System, Mental Health 116/A, 1670 Clairmont Road, Decatur, GA, USA.
- Department of Psychology, PAIS Building, Room 487, Emory University, Atlanta, GA, 30322, USA.
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, NE, 2nd Floor, Atlanta, GA, 30329, USA.
- Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA, 30322, USA.
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Dr, NE, 2nd Floor, Atlanta, GA, 30329, USA; Department of Human Genetics, Emory University School of Medicine, Whi…
Förderung
- NIMH NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of Mental Health
Zitieren
APA
Parker, D. A., Chen, M., Walker, E. F., Imes, S., Ruban, G. A., Ousley, O. Y., Henshey, B., Massa, N. M., Pearce, B., Cubells, J. F., & Duncan, E. (2026). Negative symptom dimensions link cognitive impairment to global and social functioning in 22q11.2 deletion syndrome. Schizophrenia Research. https://doi.org/10.1016/j.schres.2026.07.033
Vancouver
Parker DA, Chen M, Walker EF, Imes S, Ruban GA, Ousley OY, et al. Negative symptom dimensions link cognitive impairment to global and social functioning in 22q11.2 deletion syndrome. Schizophrenia Research. 2026. doi:10.1016/j.schres.2026.07.033
BibTeX
@article{Parker2026,
author = {Parker, David A and Chen, Marissa and Walker, Elaine F and Imes, Sidney and Ruban, Gabrielle A and Ousley, Opal Y and Henshey, Brett and Massa, Nicholas M and Pearce, Bradley and Cubells, Joseph F and Duncan, Erica},
title = {Negative symptom dimensions link cognitive impairment to global and social functioning in 22q11.2 deletion syndrome},
journal = {Schizophrenia Research},
year = {2026},
doi = {10.1016/j.schres.2026.07.033}
}
EUVIMED